There is a relationship. Institutions still maintain a 90% position in HMA. Their value has also dropped, but let's not kid ourselves. The large volumes traded in January are what led to the lower price, and the Institutions probably saw a need to reduce their positions (take some profits) all things considered.
The fact remains Institutions still maintain a large position and don't benefit from a deminished stock price either! So consider this a reflection of liquidity at a share price that maintains order, and not at all a true reflection of the real share value. Consider this rather an opportunity to buy into a company that has a much greater value than todays quoted price. As for the analyst and brokers; they are correct with their favorable recommendations, but remember that they are in the business of selling stock that they recommend, and make money no matter what the trade price is. With reduced or flat earnings the momentum will remain low, and caution is still advised if you expect a quick sustained turn up. Flat earnings will not attract enough buyers to match the imbalance of sellers, so the trend may continue downward. That said, this is a great long term investment and the elevator will go back up one day. Question is when to get on, and that's up to you. Forget the analyst and do some basic DD!
out today maintains it's strong buy with a target of $18. Says that Schoen and Ray are to talk at Merrill conference on the 14th. Earnings are out on the 20th, and HMA will host a luncheon for the investment community the same day. They also have 2 additional LOI outstanding...no mention of any concerns about integration of the new acquisitions. IMO HMA isn't planning to report bad numbers then get beat up at lunch!! Yesterday's price action was clearly disappointing, but yesterday's action reflected a 2 tier market regardless of the DOW's gain (which ain't good overall). However, if Merrill's correct, we've got 50% + on the upside. Long HMA and adding.